183 related articles for article (PubMed ID: 6006070)
21. Effect of B.1912, a new riminophenazine derivative in murine leprosy.
Chang YT
Int J Lepr Other Mycobact Dis; 1970; 38(4):417-21. PubMed ID: 5534494
[No Abstract] [Full Text] [Related]
22. Evaluation of B.663 in human leprosy.
Atkinson AJ; Sheagren JN; Rubio JB; Knight V
Int J Lepr Other Mycobact Dis; 1967; 35(2):119-27. PubMed ID: 5338956
[No Abstract] [Full Text] [Related]
23. The histoid leproma. Its characteristics and significance.
Rodriguez JN
Int J Lepr Other Mycobact Dis; 1969; 37(1):1-21. PubMed ID: 5817631
[No Abstract] [Full Text] [Related]
24. Therapy of leprosy.
Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; Martínez Domínguez V
Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
[TBL] [Abstract][Full Text] [Related]
25. [Results of bacilloscopy practiced on 360 leprosy patients, treated for over 5 years by sulfone monotherapy and examined at Bamako (Mali)].
Baquillon G; Ferracci C; Ridel PR; Saint-André P; Pattyn SR
Acta Leprol; 1981; 85():25-39. PubMed ID: 6805233
[No Abstract] [Full Text] [Related]
26. Clinical stages in sulfone treatment of leprosy.
Rodriguez JN
Int J Lepr Other Mycobact Dis; 1970; 38(2):199-203. PubMed ID: 4920411
[No Abstract] [Full Text] [Related]
27. [On the chemoresistance of the Hansen bacillus and the treatment of leprosy with drug associations].
Floch HA
Bull Soc Pathol Exot Filiales; 1966; 59(2):188-92. PubMed ID: 6012833
[No Abstract] [Full Text] [Related]
28. [Current concepts in the treatment of Hansen's disease].
Languillon J
Acta Leprol; 1980; (81):49-57. PubMed ID: 6785983
[No Abstract] [Full Text] [Related]
29. The promin treatment of leprosy. A progress report.
Faget GH; Pogge RC; Johansen FA; Dinan JF; Prejean BM; Eccles CG
Int J Lepr Other Mycobact Dis; 1966; 34(3):298-310. PubMed ID: 5950351
[No Abstract] [Full Text] [Related]
30. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
Schulz EJ
Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
[No Abstract] [Full Text] [Related]
31. [Control of leprosy: fantasies and possibilities].
Browne SG
Acta Leprol; 1980; (81):27-33. PubMed ID: 6785980
[No Abstract] [Full Text] [Related]
32. [Leprosy research].
Luger A
Wien Klin Wochenschr; 1971 Mar; 83(10):161-5. PubMed ID: 4327066
[No Abstract] [Full Text] [Related]
33. [Activity of B663 in lepromatous leprosy. Therapeutic trial].
Pene P; Carrie J; Bourgeade A; Bolliot Y
Bull Soc Pathol Exot Filiales; 1971; 64(4):407-15. PubMed ID: 5172361
[No Abstract] [Full Text] [Related]
34. The evaluation of present antileprosy compounds.
Browne SG
Adv Pharmacol Chemother; 1969; 7():211-51. PubMed ID: 4910168
[No Abstract] [Full Text] [Related]
35. Treatment of leprosy with a phenazine derivative (B 663 or G 30 320)--clofazimine.
Gatti JC; Cardama JE; Balina LM; Crespi HG; Bianchi O; Santabaya E; Farina MH
Lepr Rev; 1970 Apr; 41(2):89-92. PubMed ID: 5453084
[No Abstract] [Full Text] [Related]
36. Story behind the clinical trial of B.663 in leprosy.
Chang YT
Int J Lepr Other Mycobact Dis; 1967; 35(1):78-80. PubMed ID: 6067040
[No Abstract] [Full Text] [Related]
37. [Lampren in the treatment of leprosy].
Ahrens T
Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
[No Abstract] [Full Text] [Related]
38. [Action of 2 new products, thalidomide and B. 663 on reactive forms of Hansen's disease].
Languillon J
Med Trop (Mars); 1969; 29(4):497-503. PubMed ID: 5403099
[No Abstract] [Full Text] [Related]
39. [Treatment of leprosy by sulfones and delayed-action sulfonamides: comparison of therapeutic results in 100 cases].
Privat Y; Faye I; Bellossi A
Mars Med; 1968; 105(3):276-80. PubMed ID: 5754252
[No Abstract] [Full Text] [Related]
40. The use of B 663 (clofazimine) in the treatment of Chinese leprosy patients with chronic reaction.
Warren AG
Lepr Rev; 1970 Apr; 41(2):74-82. PubMed ID: 5453082
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
